Skip to main content

Health Policy and the Management of Antimicrobial Resistance in LMICs

Cross Journal Series

Health Policy and the Management of Antimicrobial Resistance in LMICs

Introduction

In low and middle income countries diagnostic, financial and infrastructural constraints mean the risk of emerging antimicrobial resistance is high. This can lead to excessive or inappropriate use of anti-infectives, and so the implementation of appropriate policies to regulate their use and curb the emergence of resistant microbial threats is consequently more important now than ever.  As recognised in the Goal 3 of the WHO's Sustainable Development Goals, concerted effort is required to tackle this threat, and  to highlight the challenges and developments within antimicrobial drug policies in low and middle income countries.

Aims and Scope

We are proud to present a cross-journal series to highlight the challenges and developments made within antimicrobial drug policies in low and middle income countries. We invited both reviews and original research to bring together articles on this topic in one place articles.


The following journals participated in this collection:
Antimicrobial Resistance & Infection Control
Journal of Pharmaceutical Policy and Practice
Global Health Research and Policy
Infectious Diseases of Poverty
Gut Pathogens


  1. Antibiotic resistance (ABX-R) is alarming in lower/middle-income countries (LMICs). Nonadherence to antibiotic guidelines and inappropriate prescribing are significant contributing factors to ABX-R. This study...

    Authors: Kashif Hussain, Muhammad Faisal Khan, Gul Ambreen, Syed Shamim Raza, Seema Irfan, Kiren Habib and Hasnain Zafar
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:69
  2. Antimicrobial resistance (AMR) is of growing concern globally and AMR status in sub-Saharan Africa (SSA) is undefined due to a lack of real-time data recording, surveillance and regulation. World Health Organi...

    Authors: Linzy Elton, Margaret J. Thomason, John Tembo, Thirumalaisamy P. Velavan, Srinivas Reddy Pallerla, Liã Bárbara Arruda, Francesco Vairo, Chiara Montaldo, Francine Ntoumi, Muzamil M. Abdel Hamid, Najmul Haider, Richard Kock, Giuseppe Ippolito, Alimuddin Zumla and Timothy D. McHugh
    Citation: Antimicrobial Resistance & Infection Control 2020 9:145
  3. Sub-Saharan African countries are transitioning to dolutegravir-based regimens, even for patients with extensive previous drug exposure, including first-generation integrase strand-transfer inhibitors (INSTI) ...

    Authors: Joseph Fokam, Desire Takou, Ezechiel Ngoufack Jagni Semengue, Georges Teto, Grace Beloumou, Beatrice Dambaya, Maria-Mercedes Santoro, Leonella Mossiang, Serge Clotaire Billong, Fatim Cham, Samuel Martin Sosso, Edith Saounde Temgoua, Aubin Joseph Nanfack, Sylvie Moudourou, Nelly Kamgaing, Rachel Kamgaing…
    Citation: Antimicrobial Resistance & Infection Control 2020 9:143
  4. Gonorrhea is the second most common sexually transmitted bacterial infection (STI) next to Chlamydia. Untreated cases could results in major complications like pelvic inflammatory disease (PID), ectopic pregna...

    Authors: Awoke Derbie, Daniel Mekonnen, Yimtubezinash Woldeamanuel and Tamrat Abebe
    Citation: Antimicrobial Resistance & Infection Control 2020 9:138
  5. Extended-spectrum beta-lactamase (ESBL)-producing Gram-negative bacteria have become a serious threat to global health. Their rapid spread is associated with high mortality due to ineffective antibiotic treatm...

    Authors: Tafese B. Tufa, Andre Fuchs, Takele B. Tufa, Loraine Stötter, Achim J. Kaasch, Torsten Feldt, Dieter Häussinger and Colin R. Mackenzie
    Citation: Antimicrobial Resistance & Infection Control 2020 9:128

    The Correction to this article has been published in Antimicrobial Resistance & Infection Control 2020 9:140

  6. Resistant strains of bacteria are rapidly emerging with increasing inappropriate use of antibiotics rendering them less efficacious. Self-purchasing of antibiotics particularly for viral infections is a key dr...

    Authors: Zikria Saleem, Mohamed Azmi Hassali, Brian Godman, Munazzah Fatima, Zeenia Ahmad, Areeba Sajid, Inaam Ur Rehman, Muhammad Umer Nadeem, Zaida Javaid, Madeeha Malik and Azhar Hussain
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:26
  7. This study was aimed to explore the secular trends of antibiotic utilisation in China’s hospitals over an 8-year period.

    Authors: Haishaerjiang Wushouer, Yue Zhou, Xi Zhang, Mengyuan Fu, Daiming Fan, Luwen Shi and Xiaodong Guan
    Citation: Antimicrobial Resistance & Infection Control 2020 9:53
  8. The overuse of antimicrobials in food animals and the subsequent contamination of the environment have been associated with development and spread of antimicrobial resistance. This review presents information ...

    Authors: Zuhura I. Kimera, Stephen E. Mshana, Mark M. Rweyemamu, Leonard E. G. Mboera and Mecky I. N. Matee
    Citation: Antimicrobial Resistance & Infection Control 2020 9:37
  9. The accurate assessment of antimicrobial use (AMU) requires relating quantities of active ingredients (AAIs) with population denominators. These data can be used to prioritize potential sources of selective pr...

    Authors: Juan J. Carrique-Mas, Marc Choisy, Nguyen Van Cuong, Guy Thwaites and Stephen Baker
    Citation: Antimicrobial Resistance & Infection Control 2020 9:16
  10. Dispensary and use of antibiotics without prescriptions from qualified providers is a common practice in countries with poor pharmaceutical regulations and where due focus is not given to rational use. This pr...

    Authors: Eyosait Mekonnen Koji, Gebremedhin Beedemariam Gebretekle and Tinsae Alemayehu Tekle
    Citation: Antimicrobial Resistance & Infection Control 2019 8:119
  11. Antibiotic resistance is by far one of the most important health threats of our time. Only a global concerted effort of several disciplines based on the One-Health concept will help in slowing down this proces...

    Authors: Esther-Maria Antão, Szilvia Vincze, Regina Hanke, Lukas Klimmek, Katarzyna Suchecka, Antina Lübke-Becker and Lothar H. Wieler
    Citation: Gut Pathogens 2018 10:52
  12. Poverty increases the risk of contracting infectious diseases and therefore exposure to antibiotics. Yet there is lacking evidence on the relationship between income and non-income dimensions of poverty and an...

    Authors: Vivian Alividza, Victor Mariano, Raheelah Ahmad, Esmita Charani, Timothy M. Rawson, Alison H. Holmes and Enrique Castro-Sánchez
    Citation: Infectious Diseases of Poverty 2018 7:76
  13. Bacterial diarrhea is one of the most common causes for medical consultations, mortality and morbidity in the world. Diarrheagenic Escherichia coli (DEC) and non-typhoidal Salmonella (NTS) are major intestinal pa...

    Authors: Shun-Xian Zhang, Yong-Ming Zhou, Li-Guang Tian, Jia-Xu Chen, Rita Tinoco-Torres, Emmanuel Serrano, Shi-Zhu Li, Shao-Hong Chen, Lin Ai, Jun-Hu Chen, Shang Xia, Yan Lu, Shan Lv, Xue-Jiao Teng, Wen Xu, Wen-Peng Gu…
    Citation: Infectious Diseases of Poverty 2018 7:53
  14. Babies are increasingly being exposed to antibiotics intrapartum in the bid to reduce neonatal and maternal deaths. Intrapartum antibiotic exposure, including even those considered safe in pregnancy, have been...

    Authors: Kwesi Boadu Mensah, Kwame Opoku-Agyeman and Charles Ansah
    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:24